Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
On April 6, 2017, my son received MMR, Varicella, and Hepatitis A (Pediatric/Adolescent 2D) at 1 year, 7 months, 20 days old. I wanted to wait but Doc said she would have to call CPS and report I said no to Vaccines. Within hours he became unusually lethargic and was difficult to wake. Over the next 2 days he developed a persistent high fever and screamed in pain inconsolably. His physician told me this was normal and advised Tylenol. His fever and pain continued. Within weeks, he lost all prior speech and developmental skills. He stopped talking entirely for years. He developed severe rashes with bowel movements that looked like chemical burns. On August 23, 2017, he required tonsil/adenoid removal and tubes for recurrent ENT issues and obstructive sleep apnea. In 2018, under care of a new pediatrician, I was told elevated aluminum; a detox regimen was started, and he began regaining speech slowly. On October 18, 2021, patient was evaluated by neuropsychologist who documented: Autism Spectrum Disorder (F84.0), Mild Intellectual Disability (F70), Language Delay (F80.2), Developmental Coordination Disorder (F82), ADHD (F90.2). Report states: Developmental milestones were normal if not advanced before 4/6/2017 vaccines. Patient experienced reaction with prolonged high fever and possible encephalopathy resulting in global delays. Beginning in 2024, patient was diagnosed with epilepsy and seizures (tonic-clonic, focal aware, and absence seizures). EEG and MRI showed no alternative cause. He continues to experience breakthrough seizures despite treatment.
No
None
None
None
April 6, 2017 Vaccines administered: MMR, Varicella, Hepatitis A Pediatric/Adolescent 2-dose. April 6 8, 2017 Onset of adverse events: lethargy, difficulty waking, persistent high fever, inconsolable screaming. No lab results at this time. August 23, 2017 ENT evaluation diagnosed Adenotonsillar Hypertrophy, Eustachian Tube Dysfunction, Obstructive Sleep Apnea of Child, Speech Delay, Recurrent Serous Otitis Media. Underwent tonsillectomy, adenoidectomy, and ear tube placement. October 18, 2021 Neuropsychological testing by Ph.D.: Diagnoses: Autism Spectrum Disorder (F84.0), Mild Intellectual Disability (F70), Language Delay (F80.2), Developmental Coordination Disorder (F82), ADHD Combined Type (F90.2). Statement: Developmental milestones were normal before receiving MMR, Varicella, and Hepatitis A on 4/6/2017. Patient experienced reaction to immunization with prolonged high fever and possible encephalopathy resulting in global delays. January 28, 2024 Neurology visit: Diagnosed with non-intractable epilepsy without status epilepticus. February 20, 2024 EEG testing: abnormal activity noted consistent with seizure disorder. October 25, 2024 Neurology evaluation: Diagnosed with Epilepsy nocturnal tonic and clonic seizures, fencer s pose, focal aware and absence seizures. November 11, 2024 Brain MRI: no structural cause found for seizures. January 27, 2025 GeneDX genetic testing: no known markers for autism or epilepsy. July 29, 2025 Prescription for Empatica seizure monitoring device due to ongoing seizures despite medication. August 25, 2025 Neurologist prescribed Cubby Bed for safety during seizures; insurance pending.